West Pharmaceutical Services (WST) Debt to Equity (2016 - 2025)
Historic Debt to Equity for West Pharmaceutical Services (WST) over the last 17 years, with Q4 2025 value amounting to $0.06.
- West Pharmaceutical Services' Debt to Equity fell 1546.13% to $0.06 in Q4 2025 from the same period last year, while for Dec 2025 it was $0.06, marking a year-over-year decrease of 1546.13%. This contributed to the annual value of $0.06 for FY2025, which is 1546.13% down from last year.
- Latest data reveals that West Pharmaceutical Services reported Debt to Equity of $0.06 as of Q4 2025, which was down 1546.13% from $0.07 recorded in Q3 2025.
- In the past 5 years, West Pharmaceutical Services' Debt to Equity registered a high of $0.14 during Q1 2021, and its lowest value of $0.03 during Q4 2023.
- Its 5-year average for Debt to Equity is $0.08, with a median of $0.08 in 2024.
- Its Debt to Equity has fluctuated over the past 5 years, first tumbled by 6717.72% in 2023, then soared by 19891.24% in 2024.
- Quarter analysis of 5 years shows West Pharmaceutical Services' Debt to Equity stood at $0.11 in 2021, then decreased by 28.94% to $0.08 in 2022, then tumbled by 67.18% to $0.03 in 2023, then soared by 198.91% to $0.08 in 2024, then dropped by 15.46% to $0.06 in 2025.
- Its Debt to Equity was $0.06 in Q4 2025, compared to $0.07 in Q3 2025 and $0.07 in Q2 2025.